A big step forward for individualized medicine: enlightened dosing of warfarin

被引：5

作者：

Elias, Darlene J. ^{[1
]}

Topol, Eric J. ^{[1
]}

机构：

[1] Scripps Clin, Scripps Res Inst, La Jolla, CA 92037 USA

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2008年 / 16卷 / 05期

关键词：

D O I：

10.1038/sj.ejhg.5201945

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：532 / 534

页数：4

共 9 条

[1] The pharmacology and management of the vitamin K antagonists [J].

Ansell, J ;

Hirsh, J ;

Poller, L ;

Bussey, H ;

Jacobson, A ;

Hylek, E .

CHEST, 2004, 126 (03) :204S-233S

[2] Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose:: a prospective study [J].

Carlquist, John F. ;

Horne, Benjamin D. ;

Muhlestein, Joseph B. ;

Lappe, Donald L. ;

Whiting, Bryant M. ;

Kolek, Matthew J. ;

Clarke, Jessica L. ;

James, Brent C. ;

Anderson, Jeffrey L. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (03) :191-197

[3] Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy [J].

Higashi, MK ;

Veenstra, DL ;

Kondo, LML ;

Wittkowsky, AK ;

Srinouanprachanh, SL ;

Farin, FM ;

Rettie, AE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13) :1690-1698

[4] Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin [J].

Kamali, F ;

Khan, TI ;

King, BP ;

Frearson, R ;

Kesteven, P ;

Wood, P ;

Daly, AK ;

Wynne, H .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) :204-212

[5]

MATTHEWS A, 2007, WALL ST J 0816

[6] Genetic-based dosing in orthopedic patients beginning warfarin therapy [J].

Millican, Eric A. ;

Lenzini, Petra A. ;

Milligan, Paul E. ;

Grosso, Leonard ;

Eby, Charles ;

Deych, Elena ;

Grice, Gloria ;

Clohisy, John C. ;

Barrack, Robert L. ;

Burnett, R. Stephen J. ;

Voora, Deepak ;

Gatchel, Susan ;

Tiemeier, Amy ;

Gage, Brian F. .

BLOOD, 2007, 110 (05) :1511-1515

[7] Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose [J].

Rieder, MJ ;

Reiner, AP ;

Gage, BF ;

Nickerson, DA ;

Eby, CS ;

McLeod, HL ;

Blough, DK ;

Thummel, KE ;

Veenstra, DL ;

Rettie, AE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2285-2293

[8] Association of warfarin dose with genes involved in its action and metabolism [J].

Wadelius, Mia ;

Chen, Leslie Y. ;

Eriksson, Niclas ;

Bumpstead, Suzannah ;

Ghori, Jilur ;

Wadelius, Claes ;

Bentley, David ;

McGinnis, Ralph ;

Deloukas, Panos .

HUMAN GENETICS, 2007, 121 (01) :23-34

[9] Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy [J].

Witt, DM ;

Sadler, EA ;

Shanahan, RL ;

Mazzoli, G ;

Tillman, DJ .

CHEST, 2005, 127 (05) :1515-1522

← 1 →